Evidence of sildenafil citrate in aphrodisiac herbal formulations marketed in San Salvador El Salvador, by HPLC-DAD and NMR 1H methodology

Authors

  • Josué R. Villacorta
  • David A. Servellón Ministerio de Educación Ciencia y Tecnología
  • Isabel L. Bazzocchi Universidad de La Laguna, España
  • David Torres- Romero

Keywords:

Sildenafil, Identification, Herbal, HPLC-DAD, NMR

Abstract

Introduction: Herbal products have been used for the treatment of many diseases and unlike conventional drugs, they are perceived as safe and harmless due to their natural origin. The adulteration of natural products used for the improvement of sexual desire is becoming recurrent nowadays. Objective: This study detects the presence and determines the pharmacological dose of sildenafil citrate, a phosphodiesterase-5 inhibitor, in presumed adulterated natural products, that are commercialized in markets and “sex-shops” type store as stimulants of sexual desire in men. Methodology: The sildenafil content in 21 herbal products was identified and determined, using chromatographic and spectroscopic techniques (CCF, HPLC-DAD, and NMR 1H). Results: There was not evidence of the presence of sildenafil in the evaluated products from the markets. However, in the sex-shop type sales, with high probabilities of acquisition of adulterated products with this active principle, concentrations found were in a range from 12.7-132.2 mg/capsule. Representing lower, intermedium and higher doses than those recommended by the FDA. Conclusion: For consumers of fraudulent herbal products, there may be an interaction of sildenafil with vasodilator medicines such as nitrates, used for angina pectoris, and congestive heart failure. These interactions, together with the adverse cardiac-type (hypotensive) effects of sildenafil, could have serious effect on the health of consumers. Strict regulation of the natural products industry in sampled sites is urged

Downloads

Author Biographies

  • Josué R. Villacorta

    Químico Farmacéutico Profesor Universitario

  • Isabel L. Bazzocchi, Universidad de La Laguna, España

    Instituto Universitario de Bio-Orgánica Antonio González, Departamento de Química Orgánica

  • David Torres- Romero

    Químico Farmacéutico Profesor Universitario.

References

Organización Mundial de la Salud. Estrategia de la OMS sobre medicina tradicional 2014-2023. ISBN 978 92 4 350609 8. http:// apps.who.int/medicinedocs/documents/s21201es/s21201es.pdf

Lenssen KGM, Bast A, de Boer A. International Perspectives on Substantiating the Efficacy of Herbal Dietary Supplements and Herbal Medicines Through Evidence on Traditional Use. Compr Rev Food Sci. 2019; 18(4):910-22. https://doi: 10.1111/1541-4337.12446

Teschke R, Andrade RJ. Drug, Herb, and Dietary Supplement Hepatotoxicity. Int J Mol Sci. 2016; 17:1488. https://doi:10.3390/ ijms17091488

Mitidieri E, Cirino G, d’ Emmanuele di Villa Bianca, Sorrentino R. Pharmacology and perspectives in erectile dysfunction in man. Pharmacol Therapeut. 2020, 107493. https:// doi.org/10.1016/j.pharmthera.2020.107493

Yafi FA, Sharlip ID, Becher EF. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction. Sex Med Rev. 2018, 6(2), 242– 52. http://doi:10.1016/j.sxmr.2017.08.001

Ventimiglia E, Capogrosso P, Montorsi F, Salonia A. The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opin Drug Saf. 2016. 15(2), 141–52. http://doi:10.1517/14740338.2016.1131818

El-Wakeel L M, Fouad FA, Saleem MD, Saber-Khalaf M. Efficacy and tolerability of sildenafil/L-arginine combination relative to sildenafil alone in patients with organic erectile dysfunction. Andrology. 2019; 8:1–5. https://doi.org/10.1111/andr.12671

Skalicka-Woźniak K, Georgiev MI, Orhan IE. Adulteration of herbal sexual enhancers and slimmers: The wish for better sexual well-being and perfect body can be risky. Food Chem Toxicol. 2016; 108(Pt B): 355–64. https://doi.org/10.1016/j.fct.2016.06.018

Kloner RA. Cardiovascular risk and sildenafil. Am J Cardiol. 2000; 20;86(2A):57F-61F. http:// doi: 10.1016/s0002-9149(00)00895-x

Alloggiamento T, Zipp C, Raxwal VK, Ashley E, Dey S, Levine VF. Sex, the heart, and sildenafil. Curr Prob Cardiology. 2001; 26(6):388-415. https://doi.org/10.1067/ mcd.2001.115367

Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. England BMJ. 2001; 322(7287): 651–2. http:// doi: 10.1136/bmj.322.7287.651

Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Kaul S, Russel RO, Zusman RM. Use of sildenafil (Viagra) in patients with cardiovascular disease. J Am Coll Cardiol. 1999; 99(1):168-77. http://doi: 10.1161/01. cir.99.1.168

Shinlapawittayatorn K, Chattipakorn S, Chattipakorn N. Effect of sildenafil citrate on the cardiovascular system. Braz J Med Biol Res. 2005; 38: 1303-11. http://doi: 10.1590/ s0100-879x2005000900003

Jiru M, Stranska-Zachariasova M, Dzuman Z, Hurkova K, Tomaniova M, Stepan R, Hajslova J. Analysis of phosphodiesterase type 5 inhibitors as possible adulterants of botanical-based dietary supplements: extensive survey of preparations available at the Czech market. J Pharmaceut Biomed 2019; 164: 713–724. http://doi:10.1016/j. jpba.2018.11.007

Bujang BN, Chee CF, Heh CH, Abd N, Buckle RM. Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014-16. Food Addit Contam A. 2017; 34(7): 1101-9. http://dx.doi.org/10.1080/19440 049.2017.1336674

Kee CL, Ge X, Gilard V, Malet-Martino M, Low MY. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharmaceut Biomed. 2018; 147, 250–277. http://doi:10.1016/j.jpba.2017.07.031

Rocha T, Amaral JS, Oliveira MBP. Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review. Compr Rev in Food Sci F. 2015; 15(1), 43–62. https://doi.org/10.1111/1541-4337.12173

The Food and Drug Administration (FDA) Public Notification: Alpha Male Contains Hidden Drug Ingredient URL http://www.fda.gov/Drugs/ResourcesForYou/ Consumers/BuyingUsingMedicineSafely/ MedicationHealthFraud/ucm376130.htm

Agencia Española de Medicamentos y Productos Sanitarios AEMPS. Retirada del producto MAXMAN CAPSULES publicación: 19 de noviembre de 2013. URL: http://www. aemps.gob.es/informa/notasInformativas/ me d i c a m e n t o s U s o H u m a n o / medIlegales/2013/ICM_MI_12-201 3 - maxman.htm

Cai Y, Cai T-G, Shi Y, Xian-Long C, Ling-Yun M, Shuang-Cheng M, Rui-Chao L, Feng W. Simultaneous determination of eight PDE5-IS potentially adulteration in herbal dietary. J Liq Chromatogr R T. 2010; 33:1287– 306. https://doi.org/10.1080/10826076.2010.4 88979

Balayssac S, Trefia S, Gilarda V, Malet- Martinoa M, Martinoa R, Delsuc MA, 2D and 3D DOSY 1H NMR, a useful tool for analysis of complex mixtures: Application to herbal drugs or dietary supplements for erectile dysfunction. J Pharmaceut Biomed. 2009; 50 602–12. https://doi:10.1016/j.jpba.2008.10.034

The United States Pharmacopeial Convention, USP 37-NF 32 Official Monographs Section, United States of America. 2014. 4688-4689

Zhu X, Xiao S, Chen B, Zhang F, Yao S, Wan, Z, Yang D, Han H. Simultaneous determination of sildenafil, vardenafil and tadalafil as forbidden components in natural dietary supplements for male sexual potency by high-performance liquid chromatographyelectrospray ionization mass spectrometry. J Chromatogr A. 2005; 25,1066(1-2):89-95. http://doi:10.1016/j.chroma.2005.01.038

Skoog DA, Holler FJ, Nieman TA. Principios de Análisis Instrumental. 5ta. Ed. Madrid; McGraw-Hill Interamericana; 1992, 355-58.

I.C.H. Q2 (R1), International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, harmonised tripartite guideline: validation of analytical procedures: text and methodology, (2005

Shiny MH, Hongz MK, Kimy WS, Leey YJ, Jeoung YC. Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction. Food Addit Contam. 2003; 20(9):793-6. http://doi: 10.1080/0265203031000121455

Karaarslan C. Ocular Side Effects of Sildenafil That Persist Beyond 24 h A Case Series.Front Neurol. 2020. 11:67. https://doi. org/10.3389/fneur.2020.00067

Published

2023-09-29

Issue

Section

Artículos Científicos

How to Cite

Evidence of sildenafil citrate in aphrodisiac herbal formulations marketed in San Salvador El Salvador, by HPLC-DAD and NMR 1H methodology. (2023). Revista Minerva, 3(2), 34-45. https://revistas.ues.edu.sv/index.php/minerva/article/view/2505